BabakAzarbalMD
Cardiology • Los Angeles, CAAdult Congenital Heart Disease, Heart Failure & Transplantation, Interventional Cardiology
Physician
Dr. Azarbal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 UCLA Medical Plz
Ste 630
Los Angeles, CA 90024Phone+1 310-794-1200Fax+1 310-794-1211
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Interventional Cardiology, 2005 - 2006- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Cardiovascular Disease, 2002 - 2005
Cedars-Sinai Medical CenterResidency, Internal Medicine, 1998 - 2002
Tulane University School of MedicineClass of 1998
Certifications & Licensure
CA State Medical License 2000 - 2026- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- Ten-year follow-up cohort of the everolimus versus azathioprine multinational prospective study focusing on intravascular ultrasound findings.In-Cheol Kim, Randall C Starling, Kiran Khush, Elizabeth Passano, James Mirocha
The Journal of Heart and Lung Transplantation. 2024-11-01 - Donor-Transmitted Coronary Artery Disease: Another Avenue to Expand Heart Transplantation?Richard Cheng, Babak Azarbal, Jason Smith
Journal of the American College of Cardiology. 2023-08-29 - 3 citationsChange in First-year Intravascular Ultrasound Results Predicts Adverse Events in Heart Transplant Recipients: Implications for Clinical Trial Endpoints.Osamu Seguchi, Babak Azarbal, James Mirocha, Jong-Chan Youn, Elizabeth Passano
Transplantation. 2023-03-01
Press Mentions
Angioplasty May Be Feasible for Liver Transplantation Candidates with Heart DiseaseJune 22nd, 2011
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
